HY-N10273-1mg
|
MedChemexpress LLC
|
Deoxyfusapyrone [CAS 156856-32-5]
|
|
COVID-19-immunoregulation
|
|
HY-U00037-1mg
|
MedChemexpress LLC
|
Ecopladib [CAS 381683-92-7]
|
|
COVID-19-immunoregulation
|
|
HY-139504-10mg
|
MedChemexpress LLC
|
Gamcemetinib [CAS 1887069-10-4]
|
|
COVID-19-immunoregulation
|
|
HY-139504-100mg
|
MedChemexpress LLC
|
Gamcemetinib [CAS 1887069-10-4]
|
|
COVID-19-immunoregulation
|
|
HY-139504-25mg
|
MedChemexpress LLC
|
Gamcemetinib [CAS 1887069-10-4]
|
|
COVID-19-immunoregulation
|
|
HY-139504-5mg
|
MedChemexpress LLC
|
Gamcemetinib [CAS 1887069-10-4]
|
|
COVID-19-immunoregulation
|
|
HY-139504-50mg
|
MedChemexpress LLC
|
Gamcemetinib [CAS 1887069-10-4]
|
|
COVID-19-immunoregulation
|
|
HY-15427-10mg
|
MedChemexpress LLC
|
GDC-0834 [CAS 1133432-49-1]
|
|
COVID-19-immunoregulation
|
|
HY-15427-5mg
|
MedChemexpress LLC
|
GDC-0834 [CAS 1133432-49-1]
|
|
COVID-19-immunoregulation
|
|
HY-15427-50mg
|
MedChemexpress LLC
|
GDC-0834 [CAS 1133432-49-1]
|
|
COVID-19-immunoregulation
|
|
HY-15427-1mL
|
MedChemexpress LLC
|
GDC-0834 [CAS 1133432-49-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-115570-1mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-10mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-100mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-25mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-5mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-50mg
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4]
|
|
COVID-19-immunoregulation
|
|
HY-115570-1mL
|
MedChemexpress LLC
|
GW406108X [CAS 1644443-92-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10439-10mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|
HY-10439-100mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|
HY-10439-5mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|
HY-10439-50mg
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2]
|
|
COVID-19-immunoregulation
|
|
HY-10439-1mL
|
MedChemexpress LLC
|
HPGDS inhibitor 1 [CAS 1033836-12-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-126077-1mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-10mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|